These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9667368)
1. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity. Buescher ES; McWilliams-Koeppen P Pediatr Res; 1998 Jul; 44(1):37-42. PubMed ID: 9667368 [TBL] [Abstract][Full Text] [Related]
2. Soluble receptors and cytokine antagonists in human milk. Buescher ES; Malinowska I Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960 [TBL] [Abstract][Full Text] [Related]
3. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. Lantz M; Gullberg U; Nilsson E; Olsson I J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717 [TBL] [Abstract][Full Text] [Related]
4. [Bioassay of the soluble human tumor necrosis factor receptor I recombinant plasmid expression in vitro]. Xu CR; Zhang JC; Zhao CJ; Zhang YH Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):185-8. PubMed ID: 15196381 [TBL] [Abstract][Full Text] [Related]
5. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis. Bjørnhart B; Svenningsen P; Gudbrandsdottir S; Zak M; Nielsen S; Bendtzen K; Müller K Int Immunopharmacol; 2005 Jan; 5(1):73-7. PubMed ID: 15589462 [TBL] [Abstract][Full Text] [Related]
6. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116 [TBL] [Abstract][Full Text] [Related]
7. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040 [TBL] [Abstract][Full Text] [Related]
8. Persistency of high proinflammatory cytokine levels from colostrum to mature milk in preeclampsia. Erbağci AB; Cekmen MB; Balat O; Balat A; Aksoy F; Tarakçioğlu M Clin Biochem; 2005 Aug; 38(8):712-6. PubMed ID: 15953598 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha in human milk. Rudloff HE; Schmalstieg FC; Mushtaha AA; Palkowetz KH; Liu SK; Goldman AS Pediatr Res; 1992 Jan; 31(1):29-33. PubMed ID: 1375729 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes. Adamson GM; Billings RE J Pharmacol Exp Ther; 1994 Apr; 269(1):367-73. PubMed ID: 8169842 [TBL] [Abstract][Full Text] [Related]
11. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc]. Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells. Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329 [TBL] [Abstract][Full Text] [Related]
13. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins. Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442 [TBL] [Abstract][Full Text] [Related]
14. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. Selinsky CL; Howell MD Cell Immunol; 2000 Mar; 200(2):81-7. PubMed ID: 10753499 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the functional activities of two different preparations of human recombinant tumor necrosis factor alpha. Zeman K; Paleolog EM; Tchórzewski H; Szymańska B Arch Immunol Ther Exp (Warsz); 1993; 41(2):159-64. PubMed ID: 8239921 [TBL] [Abstract][Full Text] [Related]
17. Purification of type I and type II tumor necrosis factor receptors from human lung tissue. Abdolrasulnia R; Shepherd VL Am J Respir Cell Mol Biol; 1992 Jul; 7(1):42-8. PubMed ID: 1320902 [TBL] [Abstract][Full Text] [Related]
18. Rat tumour necrosis factor-alpha: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA. Rees GS; Gee CK; Ward HL; Ball C; Tarrant GM; Poole S; Bristow AF Eur Cytokine Netw; 1999 Sep; 10(3):383-92. PubMed ID: 10477395 [TBL] [Abstract][Full Text] [Related]
19. [Construction of adenoviral vector encoding soluble human sTNFRI-IgGFc cDNA and its expression in human airway smooth muscle cells (HASMCs)]. Su J; You C; Cai S; Ma L; Wang X; Wen Q; Luo W; Huang Y Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):774-9. PubMed ID: 18724696 [TBL] [Abstract][Full Text] [Related]
20. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning. Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]